Prolia 60 mg/1 mL in a single-dose prefilled syringe Images
Generic Name: denosumab
This medication has been identified as Prolia 60 mg/1 mL in a single-dose prefilled syringe. It is supplied by Amgen Inc.
Prolia is used in the treatment of Osteoporosis and belongs to the drug class miscellaneous bone resorption inhibitors. Not for use in pregnancy. Prolia 60 mg/1 mL in a single-dose prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Prolia
- Generic Name
- denosumab
- Strength
- 60 mg/1 mL in a single-dose prefilled syringe
- Availability
- Prescription only
- Drug Class
- Miscellaneous bone resorption inhibitors
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- 55513-0710
See also:
Fosamax
Fosamax (alendronate) is used to treat or prevent postmenopausal osteoporosis and steroid-induced ...
Premarin
Premarin is used to treat symptoms of menopause such as hot flashes, and vaginal dryness. Learn ...
Evenity
Evenity (romosozumab) injection is used to treat osteoporosis in postmenopausal women to reduce the ...
Reclast
Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...
Zometa
Zometa is used to treat high blood levels of calcium caused by cancer and multiple myeloma. Learn ...
Boniva
Boniva (ibandronate) is used to treat or prevent osteoporosis in women after menopause. Includes ...
Atelvia
Atelvia (risedronate) is used to treat osteoporosis in women after menopause. Includes Atelvia side ...
Xgeva
Xgeva prevents bone fractures and other skeletal conditions in people with multiple myeloma, and is ...
Evista
Evista is used to treat and prevent osteoporosis in postmenopausal women. Learn about side effects ...
More about Prolia (denosumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (375)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: miscellaneous bone resorption inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.